• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Seattle Genetics

Seattle Genetics

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. Research and Markets: Mycosis Fungoides Therapeutics Pipeline Review, H2 2014 Report Featuring Sanofi, Seattle Genetics , Inc, Echo Therapeutics, Inc. & Actelion Ltd

    Research and Markets: Mycosis Fungoides Therapeutics Pipeline Review, H2 2014 Report Featuring Sanofi, Seattle Genetics , Inc, Echo Therapeutics, Inc. & Actelion Ltd

  2. Takeda Announces Abstracts for ADCETRIS® (brentuximab vedotin) in Hodgkin Lymphoma, Systemic Anaplastic Large Cell Lymphoma and Ixazomib in Multiple Myeloma to be Presented at 56th American Society ...

    Takeda Announces Abstracts for ADCETRIS® (brentuximab vedotin) in Hodgkin Lymphoma, Systemic Anaplastic Large Cell Lymphoma and Ixazomib in Multiple Myeloma to be Presented at 56th American Society of Hematology Annual Meeting

  3. Research and Markets: Global Antibody Drug Conjugate Market Outlook 2018 Edition

    Research and Markets: Global Antibody Drug Conjugate Market Outlook 2018 Edition

  4. Bio-Path Holdings Appoints Amy P. Sing, M.D. to its Board of Directors

    Bio-Path Holdings Appoints Amy P. Sing, M.D. to its Board of Directors

  5. Research and Markets: Graft Versus Host Disease (GVHD) - Pipeline Review, H2 2014 - 38 Companies & 67 Drug Profiles

    Research and Markets: Graft Versus Host Disease (GVHD) - Pipeline Review, H2 2014 - 38 Companies & 67 Drug Profiles

  6. Our Outlook for Health-Care Stocks

    Health-care stocks are on a tear as demand slowly returns.

  7. Our Outlook for Health-Care Stocks

    With two years of stellar returns behind us, our expectations for 2013 are more muted, but some opportunities persist.

  8. Biotech ETFs: Which One Is Best Now?

    The five biotech ETFs have very different portfolios with markedly different performance.

  9. Our Outlook for Health-Care Stocks

    While we remain bullish on the sector, health-care growth depends on the economy.

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.